Kenneth Robert Carson MD , PhD, FACP

PubMed

• A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for...
  Nicole Foley, Peter A Riedell, Nancy L Bartlett, Amanda F Cashen, Brad S Kahl
  Clinical Lymphoma, Myeloma & Leukemia. 2025-05-01
• 1 citations
  Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review.
  Joseph Magagnoli, Kevin Knopf, William J Hrushesky, Kenneth R Carson, Charles L Bennett
  American Journal of Hematology. 2025-05-01
• Association between anticoagulant-related bleeding and mortality in patients with hematological malignancies and cancer-associated venous thromboembolism.
  Tzu-Fei Wang, Suhong Luo, Brian F Gage, Martin W Schoen, Amber Afzal
  Thrombosis Research. 2025-04-01

Journal Articles

• Prevalence of High Tumor Mutational Burden and Association with Survival in Patients with Less Common Solid Tumors  
  Kenneth Carson, MD, JAMA Network Open

Abstracts/Posters

• Approximating International Myeloma Working Group Uniform Response Criteria to Derive Response for Multiple Myeloma (MM) Patients Using Data from Electronic Health Rec...
  Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas
  Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Real-World Application of National Comprehensive Cancer Network (NCCN) Testing Guidelines in Diffuse Large B-Cell Lymphoma (DLBCL) Results in Underdiagnosis of Double-...
  Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes in Multiple Myeloma Based on Comorbidities and Race
  Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Cell of Origin (COO) Association with High Body Mass Index (BMI) and Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
  Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Machine Learning Based Predictive Model of 5-Year Survival in Multiple Myeloma Autologous Transplant Patients
  Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018